<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04866550</url>
  </required_header>
  <id_info>
    <org_study_id>2020-005-HIS2R</org_study_id>
    <nct_id>NCT04866550</nct_id>
  </id_info>
  <brief_title>Health in Smart Rurality: Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients</brief_title>
  <acronym>HIS2R</acronym>
  <official_title>Health in Smart Rurality: Impact on Coordination of Care of Telemonitoring and Data Centralization of Frailty Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Reims Champagne-Ardenne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Reims Champagne-Ardenne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic diseases are frequent (around 10% of the total population and 30% after 60 years) and&#xD;
      accelerate age-related functional decline. Concerning cross-border patients, use of health&#xD;
      services can be delayed given the distances, the lack of rapid road access and the limited&#xD;
      availability of public transport and the complex organization of coordinated care.&#xD;
&#xD;
      One of the ways to reduce acute exacerbations and preserve the quality of life of patients is&#xD;
      to detect warning signs early. One of the ways to do this is to use new communication&#xD;
      technologies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to assess feasibility of using a connected tablet to assess clinical&#xD;
      parameters with an alert system in frailty patients aged over 60, living at home, with heart&#xD;
      failure and / or chronic obstructive pulmonary disease, potentially requiring care&#xD;
      cross-border (France and Belgium).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Alert according to the connected tablet</measure>
    <time_frame>12 months</time_frame>
    <description>significant change in temperature (egal or more 38°), weight (variation of more than 5%), heart rate (less than 50 beats per minute or greater than 100), systolic blood pressure (less than 85 mmHg or greater than 160 mmHg) and / or oxygen saturation (variation of more than 4%)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Connected tablet</arm_group_label>
    <description>Patients aged over 60, living at home, with heart failure and / or chronic obstructive pulmonary disease, potentially requiring care cross-border (France and Belgium).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>Daily record of temperature, weight, heart rate, systolic blood pressure and oxygen saturation</description>
    <arm_group_label>Connected tablet</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged over 60, living at home, with heart failure and / or chronic obstructive&#xD;
        pulmonary disease, potentially requiring care cross-border (France and Belgium).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged over 60&#xD;
&#xD;
          -  Patients living at home&#xD;
&#xD;
          -  Patients with heart failure and / or chronic obstructive pulmonary disease,&#xD;
&#xD;
          -  Patients potentially requiring care cross-border (France and Belgium).&#xD;
&#xD;
          -  Patients agreeing to participate to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who do not speak French&#xD;
&#xD;
          -  Patients with severe cognitive impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc NOVELLA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Reims Champagne-Ardenne - CHU de Reims</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Luc NOVELLA</last_name>
    <phone>03 26 78 44 10</phone>
    <email>jlnovella@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Université de Reims Champagne-Ardenne</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Luc NOVELLA</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 27, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic diseases</keyword>
  <keyword>Aging people</keyword>
  <keyword>Cross-border care</keyword>
  <keyword>New communication technology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

